跳至主要内容
临床试验/DRKS00000116
DRKS00000116招募中不适用

Cellular and humoral mechanisms of specific immunotherapy (SIT) in respiratory type-I-allergies.

Klinik für Dermatologie und AllergologiePhilipps-Universität Marburg0 个研究点目标入组 45 人开始时间: 2009年4月16日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
45

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 65 Years(—)
性别
All

入选标准

  • Rhinoconjunctivitis allergica or allergic asthma with maximal symptoms in the springtime.
  • Immediate-type sensitisation against birch pollen in clincial tests: positive skin prick test or intracutaneous test against birch pollen.
  • Positive nasal provocation against birch pollen.
  • Sensitisation against birch pollen (and the major allergen Bet v 1) detectable in vitro.
  • Specific IgE at least of CAP-class 2 (against the classical birch pollen allergen) and at least of CAP-class 1 against recombinant Bet v 1.
  • Signed declaration of consent.

排除标准

  • Contraindication against specific immunotherapy.
  • Patients unable to give informed consent.

研究者

发起方
Klinik für Dermatologie und AllergologiePhilipps-Universität Marburg

相似试验